Australia boutique hires experienced life sciences litigator
New recruit joins from DLA Piper and will head up firm’s litigation team | Previously worked on Pfizer v Samsung Bioepis, Jusand v Rattlejack & Murray Engineering, and Pfizer v Sandoz | Follows prosecutor Chris Vindurampulle who joined in October last year.
Medtech firm takes ex-employee to court over alleged trade secrets breach
California-based company claims materials engineer emailed himself confidential information | Trade secrets related to artificial heart valve materials.
Trial set for Gilead HIV antitrust claims case
Gilead, Johnson & Johnson and others will face trial in May | Class-action suit involves allegations of anticompetitive practices.
Biotech secures CRISPR patent for COVID-19 diagnostic test
Sherlock boosts IP portfolio with exclusive US rights to patent | Technology could be used to detect malaria, TB and COVID-19.
Sanofi backed by big pharma and more in SCOTUS clash
Case focuses on the enablement scope of patents | Amici curiae argue Amgen patents are too broad | Pfizer | Eli Lilly | AstraZeneca| Sanofi | Genentech | Bayer | Gilead Sciences| Johnson & Johnson.
Law firm expands by relocating Ireland office
The move is part of a strategic plan, with a focus on patents.
US govt wades into Moderna COVID row
The pharma company is accused of using patented tech for a drug-delivery system without authorisation | Moderna sought to escape the suit by claiming that its contract with the US government conferred immunity.
Federal Circuit rejects Dartmouth College bid to overturn patent ruling
Dietary supplements containing a form of vitamin B3 found in cow’s milk are unpatentable | Judge cites Myriad noting that the “act of isolating the NR compared to how NR naturally exists in milk is not sufficient, on its own, to confer patent eligibility”.
Eye care company settles with J&J Surgical Vision for $199m
J&J had accused defendant of infringing patents related to cataract surgery | Company also complained its copyright-protected computer programs had been ripped off, alleging “piracy of a nearly unfathomable scale”.
Medtronic unit to pay $106.5 million in heart valve feud
Jury rules that a medical device infringes a pair of Colibri patents | Medtronic fails to prove patent was invalid.
